AI Article Synopsis
Article Abstract
The 76 V kappa (variable) gene segments of the human immunoglobulin kappa locus (Ig kappa) were cloned in two contigs. Within each contig the distances between the genes range from a few hundred bp to 31 kb. We have now studied the question of whether transcripts are produced from intergenic regions, from regions near the kappa locus or from V kappa orphon regions. RNAs from several cell lines were converted to cDNAs which were then hybridized to the cosmid and phage lambda clones of the locus and of the orphon regions; the conditions were chosen such that the hybridization of transcripts with repetitive elements was minimized. The expression of a rearranged V kappa gene in a lymphoid cell line was readily detected. Also, a region 46 kb downstream from C kappa (constant) and a cDNA clone from a non-lymphoid cell line hybridizing to this region were studied in some detail. No transcripts were found, however, to be derived from the intergenic regions of the germ-line kappa locus which is in keeping with current ideas on the evolution of the V kappa multigene family.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0378-1119(95)00161-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mice carrying the full-length human immunoglobulin loci produce antigen-specific human antibodies with the lambda light chain.
iScience
December 2024
Department of Chromosome Biomedical Engineering, Integrated Medical Sciences, Graduate School of Medical Sciences, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan.
The development of antibody drugs through animal immunization typically requires the humanization of host antibodies to address concerns about immunogenicity in humans. However, employing an animal model capable of producing human antibodies presents the opportunity to develop antibody drugs without the need for humanization. Despite the ratio of human immunoglobulin (Ig) κ to Igλ usage being approximately 60%:40%, the majority of approved antibody therapeutics are kappa antibodies, and the development of lambda antibodies as therapeutic agents has lagged behind.
View Article and Find Full Text PDFA large-scale multi-omics polygenic risk score analysis identified candidate risk locus associated with rheumatoid arthritis.
Joint Bone Spine
December 2024
Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, School of Public Health, Health Science Center, Xi'an Jiaotong University, No. 76 Yan Ta West Road, 710061 Xi'an, China. Electronic address:
Objective: This study aimed to investigate the associations of multi-omics polygenic risk score (PRS) and rheumatoid arthritis (RA) to identify potential genes/proteins and biological pathways.
Methods: Based on multi-omics data from 48,813 participants in the INTERVAL cohort, we calculated multi-omics PRS for 13,646 mRNAs (RNASeq), 308 proteins (Olink), 2380 proteins (SomaScan), 726 metabolites (Metabolon), and 141 metabolites (Nightingale). Using the generalized linear model, we first evaluated the associations between multi-omics PRS and RA in 58,813 UK Biobank participants.
[Methods to Increase the Efficiency of Knock-in of a Construct Encoding the HIV-1 Fusion Inhibitor, MT-C34 Peptide, into the CXCR4 Locus in the CEM/R5 T Cell Line].
Mol Biol (Mosk)
December 2024
Center of Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334 Russia.
The low knock-in efficiency, especially in primary human cells, limits the use of the genome editing technology for therapeutic purposes, rendering it important to develop approaches for increasing the knock-in levels. In this work, the efficiencies of several approaches were studied using a model of knock-in of a construct coding for the peptide HIV fusion inhibitor MT-C34 into the human CXCR4 locus in the CEM/R5 T cell line. First, donor DNA modification was evaluated as a means to improve the efficiency of plasmid transport into the nucleus.
View Article and Find Full Text PDFStat3 mediates Fyn kinase-driven dopaminergic neurodegeneration and microglia activation.
Dis Model Mech
December 2024
Department of Genetics, Development, and Cell Biology, Iowa State University, Ames, IA 50011, USA.
The Alzheimer's disease and Parkinson's disease risk locus FYN kinase is implicated in neurodegeneration and inflammatory signaling. To investigate in vivo mechanisms of Fyn-driven neurodegeneration, we built a zebrafish neural-specific Gal4:UAS model of constitutively active FynY531F signaling. Using in vivo live imaging, we demonstrated that neural FynY531F expression leads to dopaminergic neuron loss and mitochondrial aggregation in 5 day larval brain.
View Article and Find Full Text PDFNF-κB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasis.
EBioMedicine
December 2024
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA; The Case Comprehensive Cancer Center, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA; Department of Biochemistry, Case Western Reserve University, 2109 Adelbert Road, Cleveland, Ohio 44106, USA; University Hospitals-Cleveland Medical Center, 11100 Euclid Ave, Cleveland, Ohio 44106, USA; Louis Stokes Veterans Affairs Medical Center, 10701 East Blvd, Cleveland, Ohio 44106, USA. Electronic address:
Background: Nuclear factor kappa B (NF-κB) c-Rel is a psoriasis susceptibility locus, however mechanisms underlying c-Rel transactivation during disease are poorly understood. Inflammation in psoriasis can be triggered following Toll-like Receptor 7 (TLR7) signalling in dendritic cells (DCs), and c-Rel is a critical regulator of DC function. Here, we studied the mechanism of TLR7-induced c-Rel-mediated inflammation in DCs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!